Founded in 2022, Zanskar operates in Ecommerce offering a biotechnology-based, scientifically-driven pain care brand. The company focuses on providing effective solutions for muscle pains, joint pains...
Funding stage:
Seed
Last funding:
01/09/2025
Total funding:
$318.08K+
Revenue:
Investors
Employee count:
12
Last 90d
12
Last 90d
Web traffic:
859.96K
859.96K
Last 30d
Last 30d
Zanskar: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders2
Latest Filing Date30 March 2023- Funding Events1
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Zanskar
As of 31 March 2023, Zanskar's equity is held by 2 shareholders, with the top three being Anshul Mittal and Manu Kumar Mittal.
Anshul Mittal holds the largest stake in Zanskar at 50.0% as of 31 March 2023.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links